Fig. 1From: Crosstalk between VEGFR and other receptor tyrosine kinases for TKI therapy of metastatic renal cell carcinomaReceptor tyrosine kinases, including EGFR, VEGFR, FGFR, PDGFR, and IGF-1R, are shown. Activation of tyrosine kinases initiates multiple downstream signalling pathways, including PI3K/AKT, MAPK, and JAK/STAT pathways and so on, which become the basis of the crosstalk between TKsBack to article page